000			a
999			_c15917 _d15917
003			OSt
005			20220107095406.0
008			220107b xxu||||| |||| 00| 0 eng d
040			_aAIKTC-KRRC _cAIKTC-KRRC
100			_915373 _a Matole, Vinod
245			_aBrief review on ocular drug delivery system
250			_aVol.11(1), Jan-Mar
260			_aRaipur _bAsian Pharma Press _c2021
300			_a67-70p.
520			_aExcept for skin, the eye is the most easily accessible site for topical administration of a medication. Drugs are commonly applied to the eye for a localized action, on the surface, or in the interior of the eye. A major problem in ocular therapeutics is the attainment of an optimal drug concentration at the site of action. Poor bioavailability of drugs from ocular dosage forms is mainly due to the pre corneal loss factors which include tear dynamics, non-productive absorption, transient residence time in the cul-de-sac (a region near to palpebral conjunctiva), and the relative impermeability of the corneal epithelial membrane.
650		0	_94639 _aPHARMACEUTICS
700			_915374 _aShirure, Parikshit
773	0		_tAsian journal of pharmaceutical research _x2231-5683 _dRaipur Asian Pharma Press
856			_uhttps://asianjpr.com/AbstractView.aspx?PID=2021-11-1-14 _yClick here
942			_2ddc _cAR